Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Sub-Cutaneous Administration of Rituximab Triggers a Pro-Phagocytic Phenotype of Monocytic Compartment in Low-Tumor Burden Follicular Lymphoma Patients Included in the Flirt Clinical Trial, a Lysa Study

Mikael Roussel, Cedric Menard, Delphine Rossille, Julien Saint-Vanne, Joelle Dulong, Emmanuel Bachy, Herve Tilly, Delphine Pranger, Franck Morschhauser, Luc Xerri, Guillaume Cartron, Karin Tarte

Blood (2022) 140 (Supplement 1): 6462–6463.

https://doi.org/10.1182/blood-2022-169295

Published: 2022

Journal Articles

Assessment of Circulating Tumor DNA in Newly Diagnosed DLBCL Patients Randomly Treated By R-CHOP or R-High Dose Chemotherapy Plus Autologous Stem Cell Support

Fabienne Desmots-Loyer, Delphine Rossille, Mikael Roussel, Steven Le Gouill, Thierry Lamy, Noel Milpied, Thierry Fest

Blood (2021) 138 (Supplement 1): 3501.

https://doi.org/10.1182/blood-2021-145035

Published: 2021

Journal Articles

T-cell defect in diffuse large B-cell lymphomas involves expansion of myeloid-derived suppressor cells

Imane Azzaoui, Fabrice Uhel, Delphine Rossille, Celine Pangault, Joelle Dulong, Jerome Le Priol, Thierry Lamy, Roch Houot, Steven Le Gouill, Guillaume Cartron, Pascal Godmer, Krimo Bouabdallah, Noel Milpied, Gandhi Damaj, Karin Tarte, Thierry Fest, Mikael Roussel

Blood (2016) 128 (8): 1081–1092.

https://doi.org/10.1182/blood-2015-08-662783

Published: 2016

Includes: Supplemental data

Journal Articles

Cell-of-Origin (COO) Classification, BCL2 and MYC Expression Associated-Outcome in Younger Patients Treated By RCHOP Front-Line Therapy Versus Intensive Regimen Followed By Autologous Transplant for De Novo Advanced Diffuse Large B Cell Lymphoma (DLBCL) : Results of the French Prospective Multicenter Randomized Trial Goelams -075

Blood (2015) 126 (23): 3920.

https://doi.org/10.1182/blood.V126.23.3920.3920

Published: 2015

Journal Articles

T-Cell Defect in Diffuse Large B-Cell Lymphomas Involves Expansion of Myeloid Derived Suppressor Cells Expressing IL-10, PD-L1, and S100A12

Imane Azzaoui, PhD, Fabrice Uhel, MD, Delphine Rossille, PhD, Céline Pangault, PharmD PhD, Joelle Dulong, Jerome Le Priol, PhD, Thierry Lamy, MDPhD, Roch Houot, MD PhD, Steven Le Gouill, MD PhD, Guillaume Cartron, MD PhD, Pascal Godmer, MD, Krimo Bouabdallah, MD, Noel Milpied, MD PhD, Karin Tarte, PhD, Thierry Fest, MD PhD, Mikael Roussel, MD PhD

Blood (2015) 126 (23): 1478.

https://doi.org/10.1182/blood.V126.23.1478.1478

Published: 2015

Journal Articles

Validation of Elevated Blood Soluble PD-L1 As an Independent Prognostic Marker in Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)

Thierry Fest, MD PhD, James R Cerhan, MD PhD, Maher K Gandhi, PhD FRACP, FRCPath, FRCP, Imane Azzaoui, PhD, Pauline Crooks, BSc, Matthew J Maurer, MS, Noel Milpied, MD PhD, Mark S Hertzberg, MBBS PhDFRACP FRCPA, Thierry Lamy, MD PhD, Stephen M. Ansell, MD PhD, Susan L Slager, PhD, Andrew L. Feldman, MD, Mikael Roussel, MD PhD, Thomas M Habermann, MD, Herve Ghesquieres, MD PhD, Thomas E. Witzig, MD, Brian K Link, MD, Delphine Rossille, PhD

Blood (2014) 124 (21): 2998.

https://doi.org/10.1182/blood.V124.21.2998.2998

Published: 2014

Journal Articles

Diffuse Large B Cell Lymphoma (DLBCL) infiltrating T Cells Display an Activated and Exhausted Status and Are Inhibited By Ligands of Cosignaling Receptors Including PD-L1, PD-L2 and CD80 Expressed By Most DLBCL in Situ

Daniel Olive, MD, PhD, Kieu Suong Le, Mikael Roussel, MD PhD, Florence Broussais, MD, Imane Azzaoui, PhD, Delphine Rossille, Reda Bouabdallah, MD, Thierry Fest, MD PhD, Luc Xerri, Thierry Lamy, MD PhD, Céline Pangault, PharmD, PhD

Blood (2014) 124 (21): 1665.

https://doi.org/10.1182/blood.V124.21.1665.1665

Published: 2014

Journal Articles

Blood Soluble PD-L1 Protein In Aggressive Diffuse Large B-Cell Lymphoma Impacts patient’s Overall Survival

Thierry Fest, MD, PhD, Delphine Rossille, PhD, Mélanie Gressier, Pharma.D., MSc, Delphine Maucort-Boulch, MD, PhD, Diane Damotte, MD PhD, Céline Pangault, PharmD, PhD, Steven Le Gouill, MD, PhD, Karin Tarte, PharmD, PhD, Thierry Lamy, MD, PhD, Noel Milpied, MD

Blood (2013) 122 (21): 361.

https://doi.org/10.1182/blood.V122.21.361.361

Published: 2013

Journal Articles

Lymphoma Occurring Over the Age of 90: Clinical Presentation and Outcome

Adrien Trebouet, Tony Marchand, Richard Lemal, Emmanuel Gyan, MD, PhD, Florence Broussais, MD, Yann Guillermin, MD, Hélène Monjanel, Gilles Salles, MD, Steven Le Gouill, Stephanie Boulanger, Sandra Leguyader, Albert Collignon, Delphine Rossille, PhD, Catherine Thieblemont, MD, PhD, Thierry Lamy, MD, PhD, Roch Houot, MD, PhD

Blood (2012) 120 (21): 1582.

https://doi.org/10.1182/blood.V120.21.1582.1582

Published: 2012

Journal Articles

Mesenchymal stromal cells orchestrate follicular lymphoma cell niche through the CCL2-dependent recruitment and polarization of monocytes

Fabien Guilloton, Gersende Caron, Cédric Ménard, Céline Pangault, Patricia Amé-Thomas, Joëlle Dulong, John De Vos, Delphine Rossille, Catherine Henry, Thierry Lamy, Olivier Fouquet, Thierry Fest, Karin Tarte

Blood (2012) 119 (11): 2556–2567.

https://doi.org/10.1182/blood-2011-08-370908

Published: 2012

Includes: Supplemental data

Journal Articles

Whole Blood Transcriptional Profiling of DLBCL At Diagnosis: Evidence of Systemic Changes Altering T-Cell Signaling Pathways

Delphine Rossille, PhD, Céline Pangault, PharmD, PhD, Xavier Cahu, MD, Thierry Lamy, MD, PhD, Burgun Anita, MD, PhD, Noel Milpied, MD, Thierry Fest, MD, PhD

Blood (2011) 118 (21): 2435.

https://doi.org/10.1182/blood.V118.21.2435.2435

Published: 2011

Journal Articles

Mesenchymal Stromal Cells Orchestrate Follicular Lymphoma Cell Niche Through the CCL2-Dependent Recruitment and Polarization of Monocytes

Fabien Guilloton, Gersende Caron, Cédric Ménard, Céline Pangault, PharmD, PhD, Patricia Amé-Thomas, Joelle Dulong, John De Vos, Delphine Rossille, PhD, Thierry Lamy, MD, PhD, Thierry Fest, Karin Tarte

Blood (2011) 118 (21): 1566.

https://doi.org/10.1182/blood.V118.21.1566.1566

Published: 2011

Journal Articles

Follicular Lymphoma Cell Niche: Identification of a Preeminent IL-4-Dependent T FH - B Cell Axis.

Karin Tarte, PhD, Pangault Celine, PhD, Patricia Ame-Thomas, PhD, Philippe Ruminy, PhD, Delphine Rossille, Gersende Caron, PhD, Maryse Bahia, John De Vos, MD, PhD, Mikael Roussel, MD, PhD, Celine Monvoisin, Thierry Lamy, MD, PhD, Philippe Gaulard, MD, Herve Tilly, MD, Thierry Fest, MD, PhD

Blood (2009) 114 (22): 757.

https://doi.org/10.1182/blood.V114.22.757.757

Published: 2009

Journal Articles

Diagnostic Plasma-Derived Proteomic Biomarkers of Aggressive Diffuse Large B-Cell Lymphoma: Preliminary Data Based On the 075 French GEOLAMS Multicentric and Prospective Trial.

Delphine Maucort-Boulch, Marie Arlotto, Delphine Rossille, Céline Pangault, Pascal Roy, François Berger, Anita Burgun, Marie-Christine Béné, Thierry Lamy, Noel-Jean Milpied, Thierry Fest

Blood (2009) 114 (22): 2933.

https://doi.org/10.1182/blood.V114.22.2933.2933

Published: 2009

NARROW

Sub-Cutaneous Administration of Rituximab Triggers a Pro-Phagocytic Phenotype of Monocytic Compartment in Low-Tumor Burden Follicular Lymphoma Patients Included in the Flirt Clinical Trial, a Lysa Study

Assessment of Circulating Tumor DNA in Newly Diagnosed DLBCL Patients Randomly Treated By R-CHOP or R-High Dose Chemotherapy Plus Autologous Stem Cell Support

T-cell defect in diffuse large B-cell lymphomas involves expansion of myeloid-derived suppressor cells

T-Cell Defect in Diffuse Large B-Cell Lymphomas Involves Expansion of Myeloid Derived Suppressor Cells Expressing IL-10, PD-L1, and S100A12

Validation of Elevated Blood Soluble PD-L1 As an Independent Prognostic Marker in Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)

Diffuse Large B Cell Lymphoma (DLBCL) infiltrating T Cells Display an Activated and Exhausted Status and Are Inhibited By Ligands of Cosignaling Receptors Including PD-L1, PD-L2 and CD80 Expressed By Most DLBCL in Situ

Blood Soluble PD-L1 Protein In Aggressive Diffuse Large B-Cell Lymphoma Impacts patient’s Overall Survival

Lymphoma Occurring Over the Age of 90: Clinical Presentation and Outcome

Mesenchymal stromal cells orchestrate follicular lymphoma cell niche through the CCL2-dependent recruitment and polarization of monocytes

Whole Blood Transcriptional Profiling of DLBCL At Diagnosis: Evidence of Systemic Changes Altering T-Cell Signaling Pathways

Mesenchymal Stromal Cells Orchestrate Follicular Lymphoma Cell Niche Through the CCL2-Dependent Recruitment and Polarization of Monocytes

Follicular Lymphoma Cell Niche: Identification of a Preeminent IL-4-Dependent T FH - B Cell Axis.

Diagnostic Plasma-Derived Proteomic Biomarkers of Aggressive Diffuse Large B-Cell Lymphoma: Preliminary Data Based On the 075 French GEOLAMS Multicentric and Prospective Trial.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only